KabrajiLab

3 grants submitted this month to support our effort 🎯 quiescent cancer cells in #bcsm! Great work Maia Homsi and Vittal Kurisetty! @AmericanCancer @theNCI @SKabrajiMD

Perfect place for #AACR24. On Wednesday come hear about our ongoing work dissecting residual disease in #HER2+ #bcsm @RoswellPark 6939 - Residual disease after HER2 inhibition is driven by a primary tumor subpopulation expressing an ERBB2-low associated transcriptional program

Bonne chance first NIH grant! @SKabrajiMD

We will be presenting an abstract @AACR #AACR24 ! Details of format to follow. See you in San Diego! @SKabrajiMD

Dedicated #CyCIF station? Oh yes! ⁦@RoswellPark⁩ ⁦@SKabrajiMD⁩ ⁦@HiTSatHarvard⁩ ⁦@JiaRenLin⁩ ⁦@SantagataLab⁩

New lab website: who dis? @SKabrajiMD @RoswellPark roswellpark.org/research/labs/…

Introducing lab members Dr Vittal Kurisetty, HRI scientist (left), and Maia Homsi, research technologist (middle), running the first #CyCIF experiment in @KabrajiLab with @SKabrajiMD trying not to get in the way! @RoswellPark

It’s the proliferation, s—— Spatial predictors of immunotherapy response in triple-negative breast cancer | Nature nature.com/articles/s4158…

60 day Progress report: ✅ one foundation LOI submitted ✅ one federal grant submitted ✅ one scientist and one technician starting this week ✅ new collaborators ✅ new mentees ✅ fun! @SKabrajiMD @RoswellPark @SusanGKomen

It was a great first day

New beginnings! @SKabrajiMD